Researchers utilized novel LNPs to encapsulate nucleic acid drugs, significantly downregulating the cyclin-dependent kinase 4 (CDK4) gene in tumor cells and thereby regulating tumor cell proliferation [53]. The gene discussed is CDK4; the disease is neoplasm.